Recruiting NCT07333989
Effect of Biofeedback Activation on Balance in Osteoporotic Elderly
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Electromyographic (EMG) biofeedback, Balance training.
- Who it may be relevant to
- Registry conditions: Balance Problems, Elderly (People Aged 65 or More). Basic parameters: 65 years — 75 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Egypt
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Effect of Biofeedback Activation on Balance in Osteoporotic Elderly Patients
Overview
This study aimed to investigate the effect of gluteus medius activation using electromyography (EMG) biofeedback combined with balance training on balance, physical performance, gluteus medius muscle activity, and quality of life in osteoporotic elderly patients.
Interventions
- Device Electromyographic (EMG) biofeedback
a physical therapy intervention that uses auditory and visual feedback to control the contraction or relaxation of muscles. Repeated biofeedback training can induce motor learning of muscles. Biofeedback enhances the function of pelvic floor muscles by enhancing the force generation, correct timing, and coordination of the pelvic floor muscles. Electromyography Biofeedback is considered as a behavioural therapy training modality - Other Balance training
functional strength, static and dynamic balance, and gait training
Primary outcome measures
- Balance [Time frame: Base line before treatment, then one month after treatment]
Secondary outcome measures (1)
- gluteus medius activity [Time frame: Base line before treatment and reassessment after one month of treatment]
Eligibility criteria
Inclusion criteria
- All patients included in this study met the following criteria:
- Sixty patients of both sexes were diagnosed with osteoporosis confirmed by bone density test through Dual-energy X-ray absorptiometry (DEXA) scan (A T-score equal to or less than - 2.5) (Sheu and Diamond, 2016).
- Their age ranged between 65 - 75 years.
- Their BMI ranged between 25 - 29.9 kg/m2.
- They had good mentality and cognitive function.
Exclusion criteria
- The potential patients were excluded if they have one of the following criteria:
- Patients with endocrine disorders likely to be related to metabolic bone disease, such as premature ovarian failure, hypogonadism, untreated hyperthyroidism, hyperparathyroidism, adrenal insufficiency or Cushing's syndrome.
- Patients with active contagious skin conditions.
- Patients with implant devices such as pacemaker or electrical prosthesis.
- Any cardiopulmonary disorders.
- Any neuromuscular disorders.
- Any acute viral infection.
- Patients with ascites or end stage liver or kidney failure.
- Leg discrepancy.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Open label
- Primary purpose
- Treatment
Study locations
Egypt · 1 center
- General Hospital Abouhms — Abū Ḩummuş
Identifiers
NCT: NCT07333989 · P.T.REC/012/005451